News HLB Pharmaceutical Co., Ltd.

Equities

A047920

KR7047920004

End-of-day quote Korea S.E. Other stock markets 23:00:00 12/05/2024 BST			5-day change	1st Jan Change
29,300 ^KRW	-3.62%		-5.02%	+92.64%

2023	HLB innoVation Co.,Ltd. announced that it has received KRW 55.99999522 billion in funding from a group of investors	CI
2023	HLB innoVation Co.,Ltd. announced that it expects to receive KRW 55.99999522 billion in funding from a group of investors	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HLB innoVation Co.,Ltd. announced that it has received KRW 55.99999522 billion in funding from a group of investors	12/03/23	CI
HLB innoVation Co.,Ltd. announced that it expects to receive KRW 55.99999522 billion in funding from a group of investors	31/01/23	CI
HLB Pharmaceutical Co., Ltd announced that it has received KRW 20 billion in funding from JW Holdings Corporation, Prime Life & Health Co., Ltd., DongKoo Bio & Pharma Co., Ltd.	09/08/22	CI
HLB Pharmaceutical Co., Ltd announced that it expects to receive KRW 20 billion in funding from JW Holdings Corporation, Prime Life & Health Co., Ltd., DongKoo Bio & Pharma Co., Ltd.	08/08/22	CI
Verismo Therapeutics, Inc. announced that it expects to receive KRW 12.138369345 billion in funding from HLB Pharmaceutical Co., Ltd	05/04/22	CI
G-treeBNT Co., Ltd. announced that it has received KRW 95.000054256 billion in funding from a group of investors	15/11/21	CI
HLB Pharmaceutical Co., Ltd(KOSDAQ:A047920) added to S&P Global BMI Index	20/09/21	CI
HLB Therapeutics Co.,Ltd. announced that it expects to receive KRW 95.000054256 billion in funding from a group of investors	12/09/21	CI
Verismo Therapeutics, Inc. announced that it has received KRW 16.977 billion in funding from HLB Pharmaceutical Co., Ltd	26/04/21	CI
Verismo Therapeutics, Inc. announced that it expects to receive KRW 16.977 billion in funding from HLB Pharmaceutical Co., Ltd	28/03/21	CI
HLB Pharmaceutical Co., Ltd announced that it has received KRW 13.2 billion in funding	11/03/21	CI
HLB Pharmaceutical Co., Ltd announced that it expects to receive KRW 13.2 billion in funding	09/02/21	CI
Mediforum Pharmaceutical Incorporation announced that it has received KRW 20 billion in funding from EBEST Investment & Securities Co., Ltd.	18/10/20	CI
Mediforum Pharmaceutical Incorporation announced that it has received KRW 20 billion in funding from HLB Co., Ltd. and other investor.	18/10/20	CI
Mediforum Pharmaceutical Incorporation announced that it has received KRW 48.632978215 billion in funding from EBEST Investment & Securities Co., Ltd., Medi Forum Co.,Ltd., HLB Co., Ltd.	09/09/20	CI
Mediforum Pharmaceutical Incorporation announced that it expects to receive KRW 20 billion in funding from HLB Co., Ltd. and other investor	30/08/20	CI
Mediforum Pharmaceutical Incorporation announced that it expects to receive KRW 20 billion in funding from Ibest Investment Company Ltd., Hanyang Securities Co. Ltd., Investment Arm, EBEST Investment & Securities Co., Ltd.	26/04/20	CI
Mediforum Will Collaborate with Supertrans in the Manufacturing and Commercialization of Supertrans' Products in Asia, Including South Korea, China, and Japan	07/04/20	CI
SuperTrans Medical announced that it expects to receive $2 million in funding from Mediforum Pharmaceutical Incorporation	06/04/20	CI
Mediforum Pharmaceutical Incorporation announced that it expects to receive KRW 9.90000095 billion in funding	23/02/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News HLB Pharmaceutical Co., Ltd.

Equities

A047920

KR7047920004

Summary

Filters